Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

More effective methods are needed to prevent hair loss from chemotherapy.

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

MNC-QQ cell therapy improved hair growth and quality of life in men with androgenic alopecia without adverse effects.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

Reporter characteristics affect detection of hair loss from cancer therapy.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

The project aimed to understand how genetic test results affect patients' actions and feelings in dermatology.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

CEC levels may be a useful marker for predicting prostate cancer progression.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Dermoscopy is useful for many health professionals, not just dermatologists, in improving skin condition diagnoses and reducing unnecessary biopsies.